Document Detail

No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.
MedLine Citation:
PMID:  23542639     Owner:  NLM     Status:  MEDLINE    
Risk of developing drug resistance after stopping antiretroviral regimens to prevent mother-to-child HIV-1 transmission is unknown. The Mma Bana Study randomized treatment-naive pregnant women with CD4 ≥200 cells per cubic millimeter to receive either abacavir/zidovudine/lamivudine [triple nucleoside reverse transcriptase inhibitor (NRTI) arm] or lopinavir/ritonavir/zidovudine/lamivudine [protease inhibitor (PI) arm]. Drugs were discontinued after 6 months of breastfeeding. One month after discontinuation, 29 NRTI arm samples and 25 PI arm samples were successfully genotyped. No clinically significant antiretroviral resistance mutations were detected. Eight minor resistance mutations were found among 11 (20%) women (3 from NRTI arm and 8 from PI arm), occurring at similar frequencies to those reported in HIV-1 subtype C treatment-naive cohorts.
Sajini Souda; Simani Gaseitsiwe; Nathan Georgette; Kathleen Powis; Daisy Moremedi; Thato Iketleng; Jean Leidner; Claire Moffat; Anthony Ogwu; Shahin Lockman; Sikhulile Moyo; Mompati Mmalane; Rosemary Musonda; Joseph Makhema; Max Essex; Roger Shapiro
Related Documents :
829769 - The assessment of efficacy, toxicity and quality of care in long-term drug treatment.
2045839 - Drug utilization in panama.
12271879 - Pharmacy data in epidemiological studies: an easy to obtain and reliable tool.
15507499 - Informational content of official pharmaceutical industry web sites about treatments fo...
11897289 - Provision of information about drug side-effects to patients.
11725399 - Drug information center.
12532979 - International conference on harmonisation: guidance on q1d bracketing and matrixing des...
16436699 - Novel compounds active against leishmania major.
8841739 - Treatment and prophylaxis of tinea infections.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  Journal of acquired immune deficiency syndromes (1999)     Volume:  63     ISSN:  1944-7884     ISO Abbreviation:  J. Acquir. Immune Defic. Syndr.     Publication Date:  2013 Aug 
Date Detail:
Created Date:  2013-10-21     Completed Date:  2013-11-12     Revised Date:  2014-08-18    
Medline Journal Info:
Nlm Unique ID:  100892005     Medline TA:  J Acquir Immune Defic Syndr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  572-7     Citation Subset:  IM; X    
Data Bank Information
Bank Name/Acc. No.:
GENBANK/KC204763;  KC204764;  KC204765;  KC204766;  KC204767;  KC204768;  KC204769;  KC204770;  KC204771;  KC204772;  KC204773;  KC204774;  KC204775;  KC204776;  KC204777;  KC204778;  KC204779;  KC204780;  KC204781;  KC204782;  KC204783;  KC204784;  KC204785;  KC204786;  KC204787;  KC204788;  KC204789;  KC204790;  KC204791;  KC204792;  KC204793;  KC204794;  KC204795;  KC204796;  KC204797;  KC204798;  KC204799;  KC204800;  KC204801;  KC204802;  KC204803;  KC204804;  KC204805;  KC204806;  KC204807;  KC204808;  KC204809;  KC204810;  KC852928;  KC852929;  KC852930;  KC852931;  KC852932;  KC852933
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anti-HIV Agents / administration & dosage*
Antiretroviral Therapy, Highly Active / methods*
Drug Resistance, Viral*
HIV Infections / drug therapy*,  transmission,  virology*
HIV-1 / drug effects,  genetics*,  isolation & purification
Infectious Disease Transmission, Vertical / prevention & control
Molecular Sequence Data
Mutation, Missense*
Sequence Analysis, DNA
Withholding Treatment
Grant Support
Reg. No./Substance:
0/Anti-HIV Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pooled HIV-1 RNA viral load testing for detection of antiretroviral treatment failure in Kenyan chil...
Next Document:  Identification of three distinct HIV-1 founding strains responsible for expanding epidemic among men...